1Department of Clinical Hematology, Osaka City University Medical School.
Thrombopoietin (TPO) inhibits osteoclast formation and bone resorption. This effect is mediated by transforming growth factor-beta (TGF-beta) and platelet-derived growth factor (PDGF), impacting macrophage precursors.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: